Ayurveda has long understood that each person carries a constitutional signature — a unique expression of Vata, Pitta, or Kapha — that shapes their vulnerabilities, their disease patterns, and the interventions most likely to restore balance. This is a profound and clinically useful framework. But there is a gap.

Pulse diagnosis, the primary investigative tool in Ayurvedic assessment, cannot detect insulin resistance. Not because it is insufficiently refined — but because insulin resistance is a biochemical state, measurable only through blood. Specifically, through a HOMA-IR calculation derived from fasting insulin and fasting glucose levels, producing a score that ranges from below 1.0 in metabolically healthy individuals to above 2.9 in those with significant resistance. Critically, a person can carry elevated insulin resistance for five to twenty years before any diagnosable disease becomes apparent. They may present with vague fatigue, weight gain, brain fog, or mood disturbance — findings that map easily onto a Vata, Pitta, or Kapha imbalance — while the underlying metabolic driver goes entirely undetected.

This is a significant clinical blind spot. When pulse diagnosis identifies an imbalance, it is detecting something real — a disruption that is genuine and addressable. But in a client who carries undetected insulin resistance, that imbalance may itself be a downstream expression of the biochemical dysfunction. Addressing it with herbal supplements or constitutional adjustments may bring partial relief, yet the root cause continues to operate silently beneath the level that pulse diagnosis can reach. If insulin resistance were identified and reversed first, many of the imbalances detected by pulse diagnosis might resolve without needing to be the primary focus of treatment at all.

This matters because current estimates suggest that between 40 and 60% of Western adults have some degree of insulin resistance, varying by country and diagnostic threshold. It is the most prevalent undiagnosed chronic condition in the Western world, and it is now well established as the primary upstream driver of type 2 diabetes, hypertension, fatty liver disease, cardiovascular disease, many cancers, Alzheimer's disease, ADHD, irritable bowel syndrome (IBS), arthritis, OCD, and more. These are not unrelated diseases — they are expressions of a single underlying metabolic dysfunction; issues that conventional medicine typically addresses symptom by symptom, most often with pharmaceutical intervention that manages the downstream manifestation while leaving the root cause entirely untouched.

The reason for this is just structural — in other words, inbuilt in the treatment paradigm. Dietary and lifestyle interventions — specifically intermittent fasting and a very low carbohydrate diet eliminating grains and refined sugars — have been demonstrated in peer-reviewed research to reverse insulin resistance¹, and with it to resolve or significantly reduce many of the conditions listed above. But these interventions are not patentable. They cannot be prescribed in a ten-minute appointment. They require sustained coaching, accountability, and individualised adjustment over months. Healthcare systems are not designed to deliver this, and most practitioners are not trained to provide it.

This is where the Ayurvedic practitioner stands in a uniquely powerful position — and where a significant integration opportunity has, until now, been missed.

The Ayurvedic understanding of constitutional types does not simply categorise people; it predicts their specific metabolic vulnerabilities and points toward the dietary and lifestyle adjustments most likely to work for that individual. A Kapha-dominant person developing insulin resistance will present differently and respond differently to intervention than a Vata-dominant person with the same HOMA-IR score. This is precisely the kind of nuance that a one-size-fits-all nutritional protocol cannot provide — and it is the kind of nuance that the Ayurvedic model is uniquely equipped to offer.

What has not yet happened is the formal integration of insulin resistance as a recognised diagnostic baseline within Ayurvedic practice. Pulse diagnosis should be complemented, not replaced, with a HOMA-IR test as a near-universal intake assessment for new clients. This single addition would allow practitioners to identify the silent metabolic driver that underlies the majority of the chronic conditions they are already treating — and to apply the full depth of Ayurvedic constitutional understanding to reversing it.